These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11669183)

  • 21. Unilateral laterothoracic exanthem with coincident evidence of Epstein-Barr virus reactivation: exploration of a possible link.
    Zawar V; Chuh A
    Dermatol Online J; 2008 Jan; 14(1):24. PubMed ID: 18319041
    [No Abstract]   [Full Text] [Related]  

  • 22. Epstein-Barr virus: Trigger for autoimmunity?
    Kaminski HJ; Minarovits J
    Ann Neurol; 2010 Jun; 67(6):697-8. PubMed ID: 20517931
    [No Abstract]   [Full Text] [Related]  

  • 23. A shadow of Epstein-Barr virus in the pathogenesis of atopic diseases.
    Okudaira H; Shuto H; Shuto C; Chiba T; Akiyama H; Ohta I; Matsuzaki G
    Clin Exp Allergy; 2001 Jan; 31(1):18-24. PubMed ID: 11167946
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical aspects and diagnosis of Epstein-Barr virus infections].
    Witkowska-Vogtt E
    Przegl Epidemiol; 2002; 56 Suppl 4():25-33. PubMed ID: 14750257
    [No Abstract]   [Full Text] [Related]  

  • 25. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
    Piriou E; van Dort K; Otto S; van Oers MH; van Baarle D
    Clin Infect Dis; 2008 Jan; 46(2):313-6. PubMed ID: 18171268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-switching and kissing.
    Farrell PJ
    Nat Med; 2002 Jun; 8(6):559-60. PubMed ID: 12042800
    [No Abstract]   [Full Text] [Related]  

  • 27. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
    Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
    J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus infection associated hepatic lymphoma in a patient treated with methotrexate for rheumatoid arthritis.
    Soubrier M; Arrestier S; Bouloudian S; Dubost JJ; Ristori JM
    Joint Bone Spine; 2006 Mar; 73(2):218-9. PubMed ID: 16495108
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute upper gastrointestinal bleeding associated with Epstein-Barr virus reactivation in an immunocompetent patient.
    Lavín AC; Román JG; Zárate SA; Porras MC; Caviedes JR
    Am J Gastroenterol; 2009 Jan; 104(1):253-4. PubMed ID: 19098888
    [No Abstract]   [Full Text] [Related]  

  • 30. Methotrexate-related lymphoproliferative disorder with extensive vascular involvement in a patient with rheumatoid arthritis.
    Shimura C; Satoh T; Takayama K; Yokozeki H
    J Am Acad Dermatol; 2009 Jul; 61(1):126-9. PubMed ID: 19539849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oculoglandular syndrome associated with reactivated Epstein-Barr-virus infection.
    Charbel Issa P; Eis-Hübinger AM; Klatt K; Holz FG; Loeffler KU
    Br J Ophthalmol; 2008 Jun; 92(6):740, 855. PubMed ID: 18523078
    [No Abstract]   [Full Text] [Related]  

  • 32. Lack of Epstein-Barr virus infection of synovial membranes in patients with rheumatoid arthritis: comment on the article by Niedobitek et al.
    Brousset P
    Arthritis Rheum; 2000 Nov; 43(11):2614. PubMed ID: 11083292
    [No Abstract]   [Full Text] [Related]  

  • 33. [Purification and application of viral capsid antigen of Epstein-Barr virus].
    Zhou W; Gu S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):252-5. PubMed ID: 15617341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic evaluation of a new panel of assays for Epstein-Barr virus serology.
    Radtke M; Gärtner B; Franke D
    Clin Lab; 2007; 53(3-4):149-50. PubMed ID: 17447650
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased Epstein-Barr virus-specific antibody-levels in HIV-infected individuals developing primary central nervous system lymphoma.
    Gasser O; Wolbers M; Steffen I; Hirsch HH; Battegay M; Hess C
    AIDS; 2007 Jul; 21(12):1664-6. PubMed ID: 17630573
    [No Abstract]   [Full Text] [Related]  

  • 36. [Infection by Epstein-Barr virus and multiple sclerosis].
    Alonso A; Egüés Olazábal N; Ayo Martín O
    Neurologia; 2006 Jun; 21(5):249-55. PubMed ID: 16788867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relationship between Epstein-Barr virus and rheumatoid arthritis].
    Xu WD; Shi GY; Cai XH
    Zhonghua Nei Ke Za Zhi; 1985 Aug; 24(8):457-9, 509. PubMed ID: 2996850
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of Epstein-Barr Virus DNA on the Incidence and Severity of Arthritis in a Rheumatoid Arthritis Mouse Model.
    Fadlallah S; Hussein H; Jallad MA; Shehab M; Jurjus AR; Matar GM; Rahal EA
    Front Immunol; 2021; 12():672752. PubMed ID: 34040613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EBV-specific T-cell response and immunosuppression by methotrexate and TNFalpha antagonists in patients with chronic inflammatory joint disease.
    Miceli-Richard C; Mariette X
    Joint Bone Spine; 2007 Dec; 74(6):560-2. PubMed ID: 17988922
    [No Abstract]   [Full Text] [Related]  

  • 40. Microchimerism detection by human leucocyte antigen-specific quantitative-polymerase chain reaction analysis in recipients of allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes.
    Lucas KG; Nelson JL; Erickson TD; Sun Q
    Br J Haematol; 2005 May; 129(3):443-4. PubMed ID: 15842671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.